FDA approves Epioxa for keratoconus

The FDA approved Epioxa for the treatment of keratoconus, Glaukos announced in a press release.“We’re proud to announce an extraordinary milestone for keratoconus patients with the approval of Epioxa,” Thomas Burns, Glaukos chairman and CEO, told Heali…

Science Corp.’s PRIMA BCI Implant Restores Functional Central Vision to Patients with Geographic Atrophy Caused By Age-Related Macular Degeneration, a Leading Cause of Blindness, The New England Journal of Medicine Reports

ALAMEDA, Calif.–(BUSINESS WIRE)–The New England Journal of Medicine (NEJM) today published a peer-reviewed original paper with the results of a landmark clinical trial demonstrating the efficacy of Science Corporation’s PRIMA brain-computer interface…